March 22, 2017 11:05 PM ET


Company Overview of IBC Pharmaceuticals, L.L.C.

Company Overview

IBC Pharmaceuticals, L.L.C. focuses on the development of novel cancer therapeutics using proprietary pre-targeting, bi-specific antibody technologies developed at Immunotech in Marseille, France. Immunotech was later purchased by Coulter Corporation, which subsequently became part of Beckman Coulter. IBC's first product candidate is currently being evaluated in Phase I/II clinical trials in France for the therapy of tumors producing carcinoembryonic antigen, or CEA. In May 2002, Immunomedics, Inc. (Nasdaq: IMMU) acquired the remaining 43% interest in IBC Pharmaceuticals, L.L.C. from Beckman Coulter, Inc.

Morris Plains, NJ 

United States

Key Executives for IBC Pharmaceuticals, L.L.C.

IBC Pharmaceuticals, L.L.C. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact IBC Pharmaceuticals, L.L.C., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at